HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brockmann, D. Articles by Esche, H. Search for Related Content PubMed PubMed Citation Articles by Brockmann, D. Articles by Esche, H. Social Bookmarking                      What's this?

Volume 270, Number 18, Issue of May 5, pp. 10754-10763, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Dieter Brockmann , Carsten Bury , Gabriele Kröner , H.-Christoph Kirch , Helmut Esche

The early region 1A 52R polypeptide, a protein expressed exclusively by the in vivo oncogenic adenovirus subtype 12, represses the trans-activating function of the cellular transcription factor complex AP-1 consisting of c-Jun-c-Jun homodimers. In this report we demonstrate that the repression in vivo correlates with a direct physical interaction of the adenovirus protein with c-Jun in vitro. Interestingly, the 52R protein binds to the bZIP domain of c-Jun essential for dimerization and DNA binding but not to the c-Jun activation domain. This interaction does not prevent the promoter binding of c-Jun/AP-1. Moreover, the physical association between c-Jun and the TATA box-binding protein TBP is not disturbed by the 52R polypeptide. In fact, we show evidence that down-regulation of c-Jun activity by the adenoviral protein is due to the inhibition of phosphorylation of the c-Jun trans-activation domain. In vivo phosphorylation of the c-Jun activation domain is necessary for the interaction of c-Jun with specific cofactors such as CBP and therefore a prerequisite for the activation of target genes. Due to these results we propose a model in which the 52R protein represses the trans-activating function of c-Jun by preventing its phosphorylation through a specific kinase necessary for the activation of the cellular transcription factor.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. Guan, J. Jiao, and R. P. Ricciardi Tumorigenic Adenovirus Type 12 E1A Inhibits Phosphorylation of NF-{kappa}B by PKAc, Causing Loss of DNA Binding and Transactivation J. Virol., January 1, 2008; 82(1): 40 - 48. [Abstract] [Full Text] [PDF]

				P. Fax, K. S. Lipinski, H. Esche, and D. Brockmann cAMP-independent Activation of the Adenovirus Type 12 E2 Promoter Correlates with the Recruitment of CREB-1/ATF-1, E1A12S, and CBP to the E2-CRE J. Biol. Chem., March 17, 2000; 275(12): 8911 - 8920. [Abstract] [Full Text] [PDF]

				P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels Peroxisome Proliferator-activated Receptor alpha Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-kappa B and AP-1 J. Biol. Chem., November 5, 1999; 274(45): 32048 - 32054. [Abstract] [Full Text] [PDF]

				X.-F. Zhou, X.-Q. Shen, and L. Shemshedini Ligand-Activated Retinoic Acid Receptor Inhibits AP-1 Transactivation by Disrupting c-Jun/c-Fos Dimerization Mol. Endocrinol., February 1, 1999; 13(2): 276 - 285. [Abstract] [Full Text]

				P. Fax, O. Lehmkuhler, C. Kuhn, H. Esche, and D. Brockmann E1A12S-mediated Activation of the Adenovirus Type 12 E2 Promoter Depends on the Histone Acetyltransferase Activity of p300/CBP J. Biol. Chem., December 15, 2000; 275(51): 40554 - 40560. [Abstract] [Full Text] [PDF]